News

MedPage Today on MSN3d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?
A separate Danish study showed that the two mRNA vaccines were also safe, with no increase in adverse events of special ...
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and ...
Controversial vaccine official Dr. Vinay Prasad departs FDA
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
FDA's top vaccine official leaves agency after controversial decisions
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
Top FDA vaccine regulator abruptly exits post
DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...
Pulmonology Advisor1d
FDA Vaccine Chief Steps Down After Controversial Tenure
The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.
US FDA's top vaccine official Vinay Prasad leaves agency after 3 months
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure.
Novavax lifts 2025 revenue outlook after FDA milestone payment
Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...